Among the first countries globally to develop a COVID-19 vaccine, China is now kicking into high gear again to develop a new vaccine to fend off the still-emerging omicron variant, formally deemed to be a “virus of concern” by the World Health Organization.
Since the delta variant emerged and spread across the globe, the protection offered by various types of existing vaccines has been in the spotlight
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?